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Diagnosis of Food Allergy Based on
Oral Food Challenge Test
Komei Ito1 and Atsuo Urisu2
ABSTRACT
Diagnosis of food allergy should be based on the observation of allergic symptoms after intake of the suspected
food. The oral food challenge test (OFC) is the most reliable clinical procedure for diagnosing food allergy. The
OFC is also applied for the diagnosis of tolerance of food allergy. The Japanese Society of Pediatric Allergy
and Clinical Immunology issued the ‘Japanese Pediatric Guideline for Oral Food Challenge Test in Food Al-
lergy 2009’ in April 2009, to provide information on a safe and standardized method for administering the OFC.
This review focuses on the clinical applications and procedure for the OFC, based on the Japanese OFC
guideline.
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ABBREVIATIONS
OFC, oral food challenge test; IgE, immunoglobulin E; Japanese OFC Guideline, Japanese Pediatric Guideline
for Oral Food Challenge Test in Food Allergy 2009; DBPCFC, double-blind placebo-controlled food challenge;
GI, gastrointestinal; SPT, skin prick test; HRT, basophil histamine-releasing test; FPIES, food protein-induced
enterocolitis syndrome.
INTRODUCTION
Food allergies affect 12.8% of infants, 5.1% of 3-year-
olds1 and 1.3-2.6% of school-age children in Japan.
These allergies are associated with numerous social
problems in nurseries, kindergartens and schools,
particularly in terms of providing lunches to the af-
fected children,2 and in preparing for unexpected se-
vere reactions after accidental ingestion of allergic
foods.3
In 2008, the Japanese Society of School Health is-
sued a guideline for the management of allergic dis-
eases in schools (http:www.hokenkai.or.jp). This
guideline emphasized the importance of proper medi-
cal diagnosis for appropriate management of allergic
students, especially with food allergy.
Definitions and diagnosis of food allergy should be
based on the presence of clinical manifestations after
ingestion of the offending food.4 Proof of an immu-
nological mechanism, typically as the detection of
allergen-specific immunogloblin (Ig)E antibodies,
should be associated with the diagnosis, but proof of
sensitization itself without provocation is not diagnos-
tic of food allergy.5
Clinical testing to detect allergen-specific IgE anti-
bodies (ImmunoCAP FEIAⓇ, Phadia KK., Tokyo) is
widely used in Japanese pediatric practice, particu-
larly for patients with infantile atopic dermatitis, to de-
termine the allergic background of the eczema. Ex-
aminations have sometimes been performed before
the introduction of solid foods to babies, not only for
the management of eczema,6 but also to avoid unex-
pected anaphylactic reactions at the first intake of
foods to which the baby might already have been sen-
sitized through breast milk.7 Transient elimination of
sensitized foods may help to control the allergic con-
ditions of infants, but proper diagnosis of food allergy
should follow.8
Diagnosis of food allergy should be based on a con-
vincing history of allergic reactions or on the result of
an oral food challenge test (OFC).9 The OFC has
been covered by public medical insurance in Japan
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since 2006, but too few institutions can provide the
OFC to meet the needs of patients, and a standard-
ized protocol for the OFC has been absent.10
The Japanese Society of Pediatric Allergy and Clini-
cal Immunology issued the ‘Japanese Pediatric
Guideline for Oral Food Challenge Test in Food Al-
lergy 2009’ (Japanese OFC Guideline, available only
in Japanese) in April 2009, providing for the first time
information about a safe and standardized method for
administering the OFC.11 This review focuses on the
role of and practical methods for the OFC in the diag-
nosis and management of food allergy, based on the
Japanese OFC Guideline.
CHARACTERISTICS AND CROSS-REACTI-
VITIES OF FOOD ALLERGENS THAT AF-
FECT THE OCCURRENCE OF FOOD AL-
LERGY
Hen’s eggs, cow’s milk and wheat are the three major
food allergens accounting for 70% of patients who re-
quired treatment for acute reactions in 2008 in Japan.
Peanut, salmon roe, shrimp and buckwheat are the
next most common food allergens.12
Reactivity of food allergens or allergenic compo-
nents of the foods can be highly modified by cooking
methods. Hen’s egg allergens, particularly ovalbu-
min, are sensitive to denaturing by heating, resulting
in loss of IgE-binding capacity. Ovomucoid, on the
other hand, is relatively resistant to heating13 and
protease digestion.14 As a result, some patients with
egg allergy can tolerate extensively heated egg prod-
ucts, and IgE antibody to ovomucoid can offer a good
diagnostic marker to predict whether a child can eat
heat-treated eggs.15
Caseins constitute 76-86% of whole milk proteins,
and among these, αs1-casein is the major milk aller-
gen.16 This protein does not contain disulfide bonds
and shows no tertiary structure. This characteristic
structure explains why most IgE-binding epitopes are
sequential (linear) and not susceptible to heat denatu-
ration.17 Conversely, another milk allergen, β-
lactoglobulin, is highly conformational, and extensive
heating may decrease the reactivity of milk for some
patients.18
Wheat allergens can be divided into two fractions:
a water-salt soluble fraction (albumins and globulins);
and gluten (gliadin and glutenin). Wheat and other
cereal grains share a number of homologous pro-
teins, mostly in the water-salt soluble fraction,19
whereas gluten is a component exclusive to wheat.
The fact that most patients with wheat allergy can
consume other cereals, such as rice or corn, suggests
that the dominant wheat allergens and IgE epitopes
exist in components that are not cross-reactive with
other cereals. Specific IgE testing for recombinant ω-
5 gliadin can offer a good marker of immediate-type
wheat allergy or anaphylaxis in children,20 as well as
wheat-dependent exercise-induced anaphylaxis in
adults.21
Allergen components of peanut have been exten-
sively characterized, and recombinant allergens are
ready for use in research.22 However, no single re-
combinant allergen is satisfactory for the diagnosis of
peanut allergy in terms of sensitivity and specificity.23
Cross-reactivity to homologous proteins in soybeans,
Gly m 5 (vs. Ara h 1) and Gly m 6 (vs. Ara h 3),24 and
other tree nut allergens25,26 requires more extensive
study, particularly in terms of the relationship with
clinical manifestations.
Taken together, knowledge of food allergens is re-
quired to interpret the results of allergen-specific IgE
testing,27 but no single in vitro test represents an al-
ternative to a convincing history of allergic symptoms
or the OFC.
ORAL FOOD CHALLENGE TEST
DEFINITION OF THE OFC
The general methodology for the OFC is to adminis-
ter the suspected food in gradually increasing doses
under a medical setting.28 A single trial with intake of
a small amount of the suspected food at home or in
the office may help in the introduction of eliminated
foods, but is not defined as an OFC, because it is not
diagnostic of food allergy.
An open challenge refers to an OFC in which the
patient can recognize the target food without blind-
ing. The results can be definitive if the challenge
yields either negative results or positive results with
objective symptoms. This approach may be appropri-
ate for most infants or young children, because psy-
chological claims of symptoms are negligible at those
ages. However, if the patient complains only of sub-
jective symptoms such as abdominal pain or pruritus,
particularly when the patient displays anxiety about
the challenge, interpreting challenge result is diffi-
cult.
A single-blind challenge means that the patient
does not know whether the food contains the sus-
pected allergen, but the observer knows.29 A masking
effect sometimes helps to reduce psychological ef-
fects or difficulty eating in small children, but a
single-blind challenge without placebo is essentially
similar to an open challenge.
A double-blind placebo-controlled food challenge
(DBPCFC), in which both the patient and observer
are blinded to the challenge material, remains the
gold standard for diagnosing food allergy for both
clinical and scientific purposes.30 A provocation kit
containing dried powder31 of each food (whole egg,
cow’s milk, wheat and soybean) and a masking mate-
rial (strawberry puree) is provided through the Food
Provocation Network in Japan by the National Food
Allergy Research Group (Fig. 1).
AIMS AND INDICATIONS
The OFC is generally carried out for two purposes:
Oral Food Challenge Test
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Fig. 1 Provocation kit and the protocol for blind food chalenge.
Single blind/Double blind
[Medical check by doctor]
 Physical checkup
 Consulting patient’s parents
 (regarding blood-test results and their
 demand)
 After explanation, obtain signed informed
 consent.
[Food provocation kit]
 Dried food powder + strawberry puree
[Schedule]
[When doctor confirms symptom] 
 Stop the challenge and treat the symptom.
Food provocation
Time
(min) Start 15 30 45 60 90 2 h 3 h 4 h 6 h 24 h
Evaluation
dose
● ● ● ● ● ● ● ● ● ● ●
1/20 1/10 1/5 3/10 Rest
diagnosis of food allergy; or determination of toler-
ance to the allergic food.
Diagnostic OFC is typically used in three situ-
ations. First, if a patient is suffering from chronic al-
lergic conditions such as atopic dermatitis or persis-
tent gastrointestinal (GI) symptoms, and elimination
of the suspected food ameliorates the symptoms, an
OFC to confirm the recurrence of symptoms is con-
sidered to establish an accurate diagnosis. Second, if
a patient is suffering from acute allergic symptoms af-
ter eating multiple foods, and a precise history and
or in vitro diagnostic testing indicates some sus-
pected foods, definitive diagnosis of the offending
food may be achieved using the OFC. Third, and
most frequently, is with the introduction of a sensi-
tized food as confirmed by the presence of specific
IgE antibody or positive results from a skin prick test
(SPT), for the first time in life. This scenario is mostly
the case in infants with atopic dermatitis, but patients
and their family with known food allergy tend to
avoid highly allergenic foods such as peanuts, buck-
wheat and shrimp, particularly if they have ever
shown positive specific IgE titers. Careful setting of
the OFC may be needed in this case, because intro-
duction of a highly sensitized food for the first time in
life can sometimes induce severe reactions.
Diagnosis of the achievement of tolerance (out-
growing the allergy) is another important indication
for the OFC. Most infants with egg,32 milk,33 wheat34
or soybean allergies tend to outgrow these allergies
during childhood. Information on symptoms follow-
ing accidental exposure helps determine an indica-
tion for the OFC. If the patient has experienced a se-
vere reaction recently within 1 year, the OFC is not
indicated. Patients with strict avoidance of the aller-
gic food for more than 1 year may be considered for
an OFC. Information about daily consumption of
foods containing small amounts of the suspected
component is also helpful to determine indications
and procedures for the OFC.
Allergies to peanut,35 tree nuts,36 buckwheat or
shrimp, especially in older children or adults, are
thought to continue throughout life. An OFC to those
foods may not be indicated unless loss of sensitiza-
tion is confirmed by negative results from an SPT or
specific IgE test.
DECIDING ON THE CHALLENGE PROTOCOL
Selection of a challenge protocol should be based on
the safety and accuracy of the OFC.37 The total provo-
cation dose may be large enough compared to daily
consumption of the suspected food for the proper di-
agnosis of food allergy, but is sometimes considered
too high for a highly sensitized patient with a history
of severe reaction, in terms of safety. Using step-wise
procedures in the OFC may be an option, with chal-
lenge using a small amount preceding a full-dose
challenge.
The challenged food should be standardized for di-
agnosis of the food allergy. However, processed food
may be an option for patients with known food al-
lergy. Introduction of extensively heated foods,38 par-
tially digested foods or fermented food such as
“miso”, “shoyu” or “natto”, which are traditional Japa-
nese soy products,39 may be tolerated and even effec-
tive for the induction of tolerance in some patients.
Although allergenic activities of these foods are gen-
erally decreased, OFC should be considered before
introduction, because some patients experience se-
vere reactions to these foods.
Precise information on the history of the patient,
which has already been mentioned, and immunologi-
cal laboratory data are essential for deciding on the
indications and procedure for OFC.
Ito K et al.
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Fig. 2 Positive decision points for alergen-specific IgE 
titers to diagnose food alergy without food chalenge.
Age (years) <1 1 2≤
Egg white 13.0 23.0 30.0
Milk 5.8 38.6 57.3
Food Raw egg white Heated egg white
Specific IgE Egg white Ovomucoid Egg white Ovomucoid
Positive decision
points 7.38 5.21 30.7 10.8
3) Ando14
2) Komata39
Specific IgE Egg white Milk Peanut Fish
Diagnostic decision
points 7 15 14 20
1) Sampson41 (UA/ml)
Positive decision points for specific IgE antibodies,
which indicate IgE titers with over 95% probability for
positive challenge, have been proposed for some al-
lergens (Fig. 2).40 Patients with specific IgE titers
above this point may be advised to continue a re-
stricted diet without undergoing an OFC.41 Probabil-
ity curves for specific IgE titers are also helpful to
predict the probability of positive challenge.42 Even
so, OFC might be performed for highly sensitized pa-
tients to identify the threshold amount of suspected
food inducing allergic symptoms, and to provide the
patient with advice on safe levels of the food. Empha-
sis is required on the fact that specific IgE titers do
not always correlate to threshold amounts of food or
the severity of allergic symptoms.
SPT also indicates sensitization to the suspected
food,43,44 sometimes in patients with negative results
for specific IgE in serum. Results from an SPT help to
predict a positive challenge in patients with negative
or low specific IgE titers to milk or egg,45 but false
positive results are also common.
The basophil histamine-releasing test (HRT) is also
commercially available in Japan.46 High scores (Class
4) in HRT for egg white, milk and wheat suggest
more than 90% probability for positive challenge, par-
ticularly in patients who have experienced anaphy-
laxis.47 Decreased HRT titers in patients maintaining
high specific IgE titers sometimes indicate the
achievement of tolerance to the food.
SETTING AND PROCEDURES
All institutes at which OFCs are performed have to be
fully equipped for access to emergency treatment.
The site may be in-hospital, but an outpatient office or
clinic may also be suitable for some patients in whom
severe reactions are not predicted. A safe, clean and
comfortable environment, hopefully free from contact
with other patients with infectious diseases, needs to
be provided for patients to spend a long period. Well-
trained doctors or nurses should keep in touch with
the patient throughout the procedure, and the contri-
bution of a dietitian helps a great deal.48
The risks and benefits of OFC should be discussed
with the patient and parents, and written informed
consent needs to be obtained in most cases.
Before proceeding with the OFC, the patient needs
to be stable in terms of allergic symptoms and free
from any acute illness. Antihistamines should have
been discontinued for >72 h and any other medica-
tions for the treatment or prevention of allergic dis-
eases discontinued for an appropriate period based
on the duration of action, except inhaled corticoster-
oids and topical corticosteroid ointments applied on
small areas of skin lesions.
Typical challenge foods and total doses adminis-
tered are listed in Table 1. The starting dose should
be 1 g (1 ml) or less of the food.49 The typical chal-
lenge scheme is to divide the total dose into 3-6 incre-
mental doubling doses, such as 1, 2, 4, 8 and 16 g of
boiled egg white or 1, 5, 10, 25, 50 and 100 ml of milk.
A challenge with smaller doses should be considered
for patients deemed to be at risk of severe reaction,
such as 0.1 ml for the starting dose of milk.50
When processed food is used for a blind challenge,
equivalent doses of allergen content should be con-
sidered and a standardized cooking method may be
applied to minimize the variation of allergen activity.
Doses are generally given every 15-30 min over 1-2
h. A longer dosing interval might be applied for se-
vere patients or for those who have experienced a
late-onset allergic reaction after intake of the sus-
pected food. If a sign of suspicious reaction appears,
the next dose should be postponed to observe the
progress of symptoms, or the same dose should be
repeated to avoid overloading.
The patient may stay in hospital for more than 2 h
after the final dose is given or the provoked symp-
toms disappear. Upon discharge, the patient needs to
be instructed to observe the possibility of late-onset
symptoms, even after a negative (passed) challenge.
SYMPTOMS AND TREATMENTS
The expected reactions during OFC involve cutane-
ous, mucosal, respiratory, GI, cardiovascular and neu-
rological symptoms (Table 2). Parallel to the allergic
reactions observed with accidental intake, cutaneous
symptoms are most frequently observed in 80% of
positive (failed) challenges, followed by respiratory
(35%) and GI (25%) symptoms.51
Respiratory symptoms are common and need to be
treated properly. Coughing might be divided into two
categories: dry and staccato coughing estimated to be
of laryngeal origin; and productive coughing associ-
ated with wheezing or asthma.52
Oral symptoms are frequently reported at the be-
ginning of challenge, but sometimes disappear after-
ward. Distinguishing whether such symptoms are a
Oral Food Challenge Test
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Table 1 Recommended protocol for open food chalenge
SchemeTotal dose　　Initial doseStep †Chalenge foodsTarget foods
1-2-4-8 g15 g (1 egg yolk)1 g1Boiled egg yolkEgg
0.1-0.2-0.5-1-2 g2-4 g0.1 g2 ‡Boiled egg white
1-2-4-8-16 g16-32 g (1 egg)1 g3
0.1-1-2-4-8-15 ml15-30 ml0.05-0.1 ml 1Raw milkMilk
1-5-10-25-50-100 ml100-200 ml1-5 ml2
0.5-1-2-4-8-15 g15-30 g0.5 g1Udon noodle (boiled)Wheat
1-2-5-15-25-50 g50-100 g1 g2
1-2-4-8-15-30 g30-60 g1 gBoiled or baked fishFish
1-2-5-15-25-50 g50-100 g 1 gTofu (soy paste)Soy
† A stepwise chalenge protocol may be considered for high-risk patients. 
‡ Processed foods (cookies, cakes, etc.) are also available. 
Table 2 Signs and symptoms observed in OFC
Cutaneous
Pruritus, erythema, urticaria, angioedema 
Oral
Throat pain, itching of palate, tongue or lips, palatal red-
ness or hives
Mucosal
Eye sweling, tears, conjunctivitis
Upper respiratory
Rhinorhea, sneezing, and nasal obstruction 
Lower respiratory
Coughing, wheeze, dyspnea, stridor, hoarseness, chest 
tightness
Gastrointestinal
Nausea, vomiting, diarhea, abdominal pain or cramp
Cardiovascular
Hypotension, light-headedness, cold extremities, cyano-
sis, syncope, colapse
Neurological
Behavioral change, loss of activity, restlessness, dizzi-
ness, sleep
part of systemic reactions or an oral allergy syn-
drome induced by local absorption of water-soluble
allergens is difficult, but may be important.
Neurological symptoms might be a sign of sys-
temic reactions, particularly when a small child is vio-
lently frightened and crying, or suddenly turns
quiet.53 Overwhelming tiredness and sleepiness are
sometimes observed in older children associated with
GI symptoms, but without cardiovascular symptoms
like hypotension or decreased oxygen saturations.
Grading symptoms is helpful for deciding on treat-
ment strategies (Table 3). Treatment may not be nec-
essary for localized skin or mild mucosal symptoms
(Grade 1). Most skin and mucosal symptoms may be
treated using antihistamines (oral or parenteral).
Beta-agonist inhalation may be applied to mild respi-
ratory symptoms, and oxygen should be adminis-
tered if oxygen saturation falls below 95% (Grade 2,
Step 1 treatment, Fig. 3).
When symptoms reach Grade 3, Step 2 treatment
should be applied. Intramuscular adrenaline (0.01
mgkg) is the first-line treatment in Step 2. Effects of
adrenaline may be observed within 5 min, when most
skin, respiratory, GI and even neurological signs tend
to disappear. If the effect was insufficient or symp-
toms reappear after 10-15 min, repeat administration
of intramuscular adrenaline may be considered, and
additional treatments such as intravenous fluid, par-
enteral antihistamine or corticosteroids should be ap-
plied. Repeat inhalation of beta-agonists or adrena-
line54 may be an option for persistent but mild respi-
ratory symptoms.
In cases of severe reactions accompanied by intrac-
table hypotension or respiratory distress, full resusci-
tation with bolus rehydration (30 mlkg normal sa-
line), respiratory supports and catecholamine should
be applied in the intensive care unit (Step 3).
DIET MANAGEMENT BASED ON RESULTS
OF THE OFC
Based on the total dose and symptoms provoked in
the OFC, patients should be instructed about restric-
tions or re-introduction of the challenge food. Even
after a negative challenge, the amount of food intake
at home may not exceed that of the total dose at least
several times to confirm safety.
Positive challenge does not always suggest a need
for complete elimination of the food from the diet.55
Patients may introduce small amounts of the target
food within the appropriate safety range, at 1-10% of
the threshold level in general, or the processed food
in which decreased allergic reactivity is expected.
Repeated follow-up visits are needed to confirm the
benefits of the OFC, particularly when re-introduction
of the eliminated food is in progress. In many cases,
the patient and parents are anxious about the occur-
rence of allergic symptoms even after a negative chal-
lenge, or may actually experience some mild symp-
toms after eating the target food. Providing instruc-
tions to the patient’s school about restrictions to the
Ito K et al.
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Table 3 Grading of symptoms observed with oral food chalenge
NeurologicalCardiovascularRespiratory mucosalGastrointestinalSkinGrade
ーーー
Nausea
Oral/pharyngeal 
discomfort, itch
Faint rash
Wheals (<3)
Pruritus
1
Loss of activity
ー
Sneeze
Rhinorhea/nasal obstruction
Scratch nose/eyes
Cough (<10)
Vomiting/diarhea 
(1-2)
Transient colic
Localized rash
Wheals (3-10)
Worsening of eczema
Increased scratch
2
Fatigue・sleep
or iritability
Increased heart rate 
( _> 1 5 bpm)
Palor
Cough ( _> 10)
Wheeze
Husky voice/Barking cough
Dificulty swalowing
Vomiting/diarhea 
( _> 3)
Persistent colic
Systemic rash/wheals
Severe itch
Angioedema
3
Dizziness
Distraction
Arhythmia
Mild hypotension
Cold extremities
Sweat skin
Dyspnea
Weak respiration
Cyanosis
Vomiting/diarhea 
with dehydration
As above4
Loss of
consciousness
Severe bradycardia
Severe hypotension
Cardiac arest
Respiratory arestAs aboveAs above5
Grading should be based on the most severe symptom.
Fig. 3 Treatment plan for alergic symptoms. † Consider oral corticosteroid to prevent late reactions.
Skin/mucosal Gastrointestinal Respiratory Cardiovascular/Neurological
●Histamine H1 antagonist
　(oral)
●Repeat histamine H1 
　antagonists (oral, IV or IM)
●Beta-2 stimulant inhalation
●Oxygen (SpO2 <95%)
●Repeat inhalation
●Consider Step 2
●0.1% Adrenalin IM 0.01 mL/kg
●Repeat adrenalin IM after 15-20 min, or
●Oxygen (SpO2 <95%)
●Hydration. Bolus saline (30 mL/kg) in case of shock
●Corticosteroid (slow IV or drip)
　Hydrocortisone 5-10 mg/kg, Methyprednisolone or Predonine 1-2 mg/kg
●Dopamine, Noradrenalin, Glucagon for intractable circulatory failure
●Intubation and mechanical ventilation
●Cardiac massage, electronic defibrillation (AED)
Consider admission
Step
1†
Step
2
Step
3 Admission to ICU
lunch menu is an important social activity to improve
quality of life and safety of the patient.
FUTURE PROSPECTS
The Japanese OFC Guideline principally deals with
the diagnosis of immediate food hypersensitivity. Di-
agnostic food challenge for non-IgE-mediated allergic
reactions including food protein-induced enterocolitis
syndrome (FPIES)56 and late-onset worsening of ec-
zema,57 both of which are thought to be cell-mediated
Oral Food Challenge Test
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immunological disorders, is not described in the
guideline, because insufficient evidence is available to
establish a standardized protocol at this time. Indirect
food challenges such as provocation through breast
milk after giving the target food to the lactating
mother,58 or labial food challenge59 are also not dealt
with.
The guideline does not recommend a single uni-
versal procedure, but places emphasis on users ar-
ranging their own protocol to meet the conditions of
their institute and patient needs. In any case, safety
remains the most important consideration, and the
key safety point might be that OFC is conducted by
experienced staff who are present throughout the
procedure, continuously interacting with the patient.
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